Vision. Connection. Innovation.

video of the thread

about us.

Gossamer Bio is a biopharmaceutical company focused on discovering, developing, and commercializing immunology-based therapeutics in the autoimmune, allergy/inflammation, immuno-oncology and fibrosis disease areas to improve the lives of patients.

pipeline.

GB001

Phase 2 clinical program*

GB002

Phase 1 clinical program*

GB003

Preclinical program*

GB004

First-in-class, HIF-1α stabilizer, for the treatment of inflammatory bowel diseases – Phase 1 clinical program

*Targets to be disclosed

scroll